AbbVie Inc.
ABBV
$225.11
-$2.59-1.14%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -88.08% | -31.53% | -6.06% | -102.68% | -12.20% |
| Total Depreciation and Amortization | -0.77% | -3.80% | -1.69% | 1.25% | -6.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 233.21% | 26.72% | 154.29% | 279.96% | 13.17% |
| Change in Net Operating Assets | 67.07% | 83.38% | -1,144.53% | -189.62% | -71.45% |
| Cash from Operations | 28.95% | 126.90% | -59.53% | 48.29% | -28.08% |
| Capital Expenditure | -53.01% | -11.62% | -21.76% | -41.95% | -13.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 67.01% | -11.51% | 94.27% | -224.05% | -5,309.55% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -116.67% | 255.56% | 733.33% | 597.62% | 6,842.86% |
| Cash from Investing | 60.47% | -7.17% | 92.33% | -134.25% | -2,137.40% |
| Total Debt Issued | -- | -- | -72.02% | -- | -- |
| Total Debt Repaid | -400.25% | -12.13% | 40.76% | -221.18% | -20,050.00% |
| Issuance of Common Stock | -5.97% | -50.00% | -55.91% | -67.74% | 86.11% |
| Repurchase of Common Stock | 76.47% | -33.33% | 27.42% | -11,833.33% | -325.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.82% | -5.82% | -5.52% | -4.80% | -4.72% |
| Other Financing Activities | 15.63% | -- | 114.67% | 101.75% | 150.00% |
| Cash from Financing | -49.41% | 55.55% | -111.63% | -54.21% | -15.45% |
| Foreign Exchange rate Adjustments | -200.00% | 433.33% | 150.00% | -300.00% | 150.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 85.73% | 126.17% | -106.64% | -266.38% | -229.70% |